IonQ reported third-quarter 2026 revenue of $173.8m, up 336% from $39.9m a year earlier and well ahead of a consensus near $141.2m, and raised full-year 2026 revenue guidance to $505m to $515m from a prior $450m to $460m. The shares closed 6 November at $32.62, up 23.42% from a previous close of $26.43. Remaining performance obligations more than doubled to $1.2bn. On the growth evidence alone, this is the strongest set of numbers the company has produced.
What the numbers support and what would still have to go right are two different lists, and anyone asking whether IonQ is a good long-term investment needs both. The supporting evidence is revenue scale that is no longer speculative, a backlog figure of $1.2bn that implies contracted future work, and roughly $3.7bn of cash on a pro forma basis. What would have to go right is narrower and harder: roughly half of the reported revenue came from a semiconductor foundry IonQ bought rather than from quantum computing, the reported net profit came from a non-cash accounting gain rather than from operations, and the cash pile was raised by issuing equity — $2.0bn in a single October transaction — not generated by the business. The growth rate is real. The question is what it is growth in.
What actually happened
IonQ released third-quarter results after the US close on 5 November 2026. Headline revenue of $173.8m represented the sixth consecutive record quarter and, by the company's own description, lifted full-year guidance to an industry record above $500m.
The segment split is the most important disclosure in the release. The IonQ Platform segment — quantum computers, networking, sensing and security — generated $90.3m, up 127% year on year. The remaining $83.5m came from SkyWater Technology, the semiconductor foundry IonQ acquired, and covered only about two months of post-closing ownership. So of the 336% headline growth, the organic quantum business grew 127% and the balance is consolidation of an acquired foundry. Both are legitimate revenue. They are not the same business, they do not carry the same margins, and a reader who takes 336% as the growth rate of a quantum computing company has misread the release.
The same caution applies to the backlog. Remaining performance obligations of $1.2bn split into $689m from IonQ Platform and $479m from SkyWater. The quantum half of that is the number that speaks to the long-term thesis.
Profitability needs the same discipline. IonQ reported a net profit of roughly $564m for the quarter — a figure that came overwhelmingly from an $896.2m non-cash gain on warrant liabilities, which management itself said does not reflect operating performance. The operating picture is the adjusted EBITDA loss, which widened to $133.6m from $48.9m a year earlier. A company can post a reported profit and a materially wider operating loss in the same quarter, and this is what that looks like.
On the balance sheet, cash, cash equivalents and investments stood at approximately $1.7bn at 30 September 2026, rising to roughly $3.7bn pro forma for the $2.0bn equity offering that closed in October. That offering was priced on 14 October at $40.00 per unit — a premium to the $34.78 close the day before — and comprised 20.5m shares of common stock plus 29.5m pre-funded warrants, purchased by an investment entity managed by Heights Capital Management. It also carried seven-year warrants over up to 100m additional shares at an exercise price of $69.46. Separately, IonQ agreed to acquire Elisity for consideration of $1.15bn in stock at closing, with up to a further $150m tied to revenue milestones.
Why the market reacted the way it did
A 23.42% single-session gain on a results beat is a large move even by this sector's standards, and the starting point explains much of it. IonQ shares closed at $34.78 on 13 October and at $26.43 on 5 November — a fall of roughly a quarter in three weeks, driven by dilution concerns around the $2.0bn raise and the acquisition-heavy strategy behind it. The stock went into the print having already been marked down for exactly the issues the print did not resolve.
Against that setup, a revenue beat of more than 20% against consensus and a guidance raise of roughly $55m at the midpoint was enough to force a reversal. The guidance raise matters more than the beat: a beat is one quarter, a raise is a statement about the next one, and a move from $450m-$460m to $505m-$515m is a large revision for a company of this size to make with one quarter left in the year.
The move also reflected relief on a specific fear. The October equity raise had invited the reading that IonQ was issuing stock because the operating business needed funding faster than expected. Revenue 23% ahead of consensus is the most direct available rebuttal to that reading — it does not address the dilution, but it changes the story the dilution is attached to.
The Openbook read
Growth is the highest of the five factors by a wide margin and would be on almost any construction. Revenue up 336% year on year, a sixth consecutive record quarter, a guidance raise above $500m and backlog doubling to $1.2bn is as strong a growth signature as the listed market offers. The qualification is one of composition rather than degree: strip out SkyWater and the organic quantum platform grew 127%, which is still exceptional but is a different number, and the full-year guide for quantum computing growth of around 110% is the figure that describes the core business rather than the consolidated entity.
Profitability is the weakest score and the gap between it and Growth is the central tension in the stock. An adjusted EBITDA loss that widened from $48.9m to $133.6m while revenue quadrupled means losses are scaling with the business, not being absorbed by it. The reported net profit is an artefact of warrant accounting and should not move a profitability score at all — treating a non-cash $896.2m warrant gain as earnings would be the single easiest way to misprice this company. The SkyWater consolidation also changes the margin mix going forward, because foundry revenue and quantum systems revenue are not comparable at the gross line.
Solvency looks strong on the headline and needs a footnote. Roughly $3.7bn of pro forma cash against an operating loss of the current size buys a long runway, and there is no near-term funding cliff. But that position was created by issuing equity, not by generating cash, and the distinction matters for how durable it is. A solvency score reading the cash balance alone would be near the top of the range; one that asks where the cash came from, and whether the next $2bn would come on similar terms, reads lower.
Momentum is genuinely mixed, which is unusual. The 23.42% session gain and the guidance raise are strong positive revision inputs. But the stock closed 6 November roughly 6% below where it traded in mid-October, so the post-results rally recovered part of a drawdown rather than making new ground. Momentum built on a recovery from a sharp decline is less informative than momentum built on a sustained advance.
Reward/Risk is where the dilution arithmetic belongs, and it is specific. The October prospectus listed 408,907,678 shares outstanding before the offering, 429,407,678 after it, and 558,907,678 if the associated warrants were exercised in full. That is a potential increase of roughly 37% in the share count from the pre-offering base, concentrated in instruments held by a single investment manager, with the 100m-share warrant tranche struck at $69.46 — well above the current price, so it only converts if the equity story works. Add the Elisity consideration of $1.15bn in stock plus up to $150m in milestones, and a substantial part of IonQ's growth has been bought with paper. The reward/risk picture is therefore asymmetric in an unusual way: the upside case requires revenue per share to grow faster than share count, and the dilution is already contracted while the revenue is not.
Put together, the five factors describe a company whose growth score and whose profitability and dilution scores are both accurate and point in opposite directions. The long-term answer turns on whether platform access and pilot contracts convert into repeat, high-margin revenue — not on the headline growth rate, which the SkyWater consolidation has made a poor guide to the underlying business.
The read-across
The quantum complex traded as one asset on 6 November. Rigetti Computing and D-Wave Quantum both rose by mid-to-high-teens percentages on IonQ's results despite having no news of their own, which tells you the group is still priced on sector sentiment rather than on individual contract books. That correlation cuts both ways and is worth remembering when IonQ next disappoints.
The more interesting read-across is the one IonQ's own structure creates. By consolidating a semiconductor foundry, IonQ has become partly a manufacturing business with the comparability problems that brings — its revenue line is no longer directly comparable to peers whose revenue is entirely quantum. Rigetti's revenue base remains a small fraction of IonQ's, and investors using revenue multiples across the group on the Openbook screener will now be comparing different things unless they use the Platform segment figure. SkyWater's role as a foundry partner to others in the sector also means IonQ now sits on both sides of some commercial relationships.
For the broader market, the signal is narrower than the price action suggests. A 336% consolidated growth rate in quantum computing does not establish that enterprise demand for quantum capacity has inflected; the $689m of Platform remaining performance obligations is the figure that would, over time, do that.
What to watch next
- Full-year 2026 results against the $505m-$515m guide. With one quarter to run, the range is tight enough that a miss would be meaningful. The segment split within it matters more than the total.
- The quantum computing growth figure of around 110% for the full year, which is the cleanest available measure of the core business stripped of SkyWater.
- Adjusted EBITDA direction. The loss widened from $48.9m to $133.6m year on year. Whether that loss grows faster or slower than revenue in the next print is the operating-leverage test.
- Platform remaining performance obligations, at $689m this quarter. Growth here is contracted future quantum revenue; growth only in the SkyWater half is not the same thing.
- Share count and warrant movement. The gap between 429.4m shares and 558.9m fully diluted is the dilution that has already been agreed, plus Elisity's $1.15bn in stock and up to $150m of milestone consideration.
- Elisity integration and its revenue milestones, which determine whether the additional $150m becomes payable.
The growth is not in question. What is in question is how much of it reaches a shareholder whose claim on it is being divided.
Discussion
Log in to join the discussion